Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $3.5 million.

  • Iradimed's Net Cash Flow rose 1081.19% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 343.31%. This contributed to the annual value of $2.5 million for FY2024, which is 13014.77% up from last year.
  • As of Q3 2025, Iradimed's Net Cash Flow stood at $3.5 million, which was up 1081.19% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Iradimed's Net Cash Flow registered a high of $4.4 million during Q2 2021, and its lowest value of -$15.2 million during Q1 2023.
  • For the 5-year period, Iradimed's Net Cash Flow averaged around $339864.4, with its median value being $2.7 million (2025).
  • Per our database at Business Quant, Iradimed's Net Cash Flow surged by 43062.35% in 2021 and then tumbled by 167634.74% in 2022.
  • Quarter analysis of 5 years shows Iradimed's Net Cash Flow stood at $3.6 million in 2021, then tumbled by 34.71% to $2.4 million in 2022, then increased by 27.37% to $3.0 million in 2023, then crashed by 83.0% to $512856.0 in 2024, then surged by 588.37% to $3.5 million in 2025.
  • Its Net Cash Flow was $3.5 million in Q3 2025, compared to $2.7 million in Q2 2025 and -$1.9 million in Q1 2025.